Freesolve RMS

DEVICE2 trials

Sponsors

Biotronik AG, Teleflex

Conditions

Acute Coronary SyndromeAngina PectorisArterial Occlusive DiseasesArteriosclerosisAtherosclerosis, CoronaryCardiovascular DiseasesChest PainCoronary Artery Disease

Unknown Phase

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System

Active, not recruitingNCT05540223

Biotronik AGAcute Coronary Syndrome, Angina Pectoris, Atherosclerosis, Coronary +3

Start: 2024-05-13End: 2032-02-01Updated: 2026-07-07

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions

RecruitingNCT07258290

TeleflexAcute Coronary Syndrome, Angina Pectoris, Arterial Occlusive Diseases +12

Start: 2026-06-11End: 2033-06-01Target: 1859Updated: 2026-08-31

Related Papers

Safety and performance of the third-generation drug-eluting resorbable coronary magnesium scaffold system in the treatment of subjects with de novo coronary artery lesions: 6-month results of the prospective, multicenter BIOMAG-I first-in-human study.

2023-04-1728 citations